Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

Medicare's approach to adjust for use of novel oncology therapies in value-based oncology programs provides financial protection for some high-use practices

Adjusting for Novel Therapy Use Key to Value-Based Programs

Evaluation of Medicare's Oncology Care Model shows adjustment offers financial protection
National Cancer Institute-designated cancer centers are endorsing the goal of eliminating cancers caused by the human papillomavirus (HPV) through HPV vaccination and evidence-based cancer screening

NCI Cancer Centers Endorse Goal of Eliminating HPV Cancers

HPV vaccine, screening offer opportunity to prevent 12,000 cervical CAs, 40,000 HPV-linked CAs/year

May 2018 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for May 2018. This roundup includes...
Cryoablation is effective for controlling cancer pain without many side effects

Cryoablation Efficacious for Cancer Pain, Review Finds

Cryoablation also cuts the need for opioids at 24 hours post-treatment and at three months
For patients with active cancer and venous thromboembolism (VTE)

Rivaroxaban Linked to Low VTE Recurrence in Active Cancer

Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin
For patients with advanced cancers

Immune Checkpoint Inhibitor Efficacy Varies by Sex

Magnitude of benefit of immune checkpoint inhibitors sex-dependent for patients with advanced cancers
Many oncologists recommend medical marijuana clinically despite not feeling sufficiently knowledgeable about its utility

Many Oncologists Discuss, Recommend Medical Marijuana

But majority of oncologists don't feel knowledgeable enough to make these recommendations
Among women with metastatic cancer and dependent children

Parenting Fears Harm Well-Being of Women With Metastatic Cancer

Findings based on survey of women with advanced cancer and dependent children
The cancer burden among persons living with HIV is projected to shift by 2030

Cancer Incidences and Burden Expected to Shift in HIV-Positive

Prostate and lung cancer expected to emerge as the most common types by 2030
Specific demographic groups have lower cancer genetic testing

Gender Disparity Observed in Cancer Genetic Testing in the U.S.

Unaffected men have rate of breast/ovarian cancer testing that is one-tenth that of unaffected women